InsiderClue
Insiders · Profile

Fitzgerald Kevin Joseph

CSO & EVP, Head of Research at ALNYLAM PHARMACEUTICALS. Filing since 25 Jun 2024. CIK 0001886431

Company
Date
Role
Action
Shares
Amount
Of holding
ALNY ALNYLAM PHARMACEUTICALS, INC.
5 Mar 2026
CSO & EVP, Head of Research
Sold on a plan
658
$213.18K
3.1%
ALNY ALNYLAM PHARMACEUTICALS, INC.
4 Mar 2026
CSO & EVP, Head of Research
Sold on a plan
633
$204.51K
2.9%
ALNY ALNYLAM PHARMACEUTICALS, INC.
3 Mar 2026
CSO & EVP, Head of Research
Sold on a plan
1,652
$528.19K
7.0%
ALNY ALNYLAM PHARMACEUTICALS, INC.
2 Mar 2026
CSO & EVP, Head of Research
Sold on a plan
1,598
$523.58K
6.4%
ALNY ALNYLAM PHARMACEUTICALS, INC.
17 Feb 2026
CSO & EVP, Head of Research
Sold on a plan
2,041
$677.53K
8.8%
ALNY ALNYLAM PHARMACEUTICALS, INC.
13 Feb 2026
CSO & EVP, Head of Research
Sold on a plan
1,959
$607.45K
7.8%
ALNY ALNYLAM PHARMACEUTICALS, INC.
13 Jan 2026
CSO & EVP, Head of Research
Sold on a plan
2,290
$848.06K
9.7%
ALNY ALNYLAM PHARMACEUTICALS, INC.
12 Jan 2026
CSO & EVP, Head of Research
Sold on a plan
1,510
$547.93K
6.0%
ALNY ALNYLAM PHARMACEUTICALS, INC.
17 Nov 2025
CSO & EVP, Head of Research
Sold on a plan
12,128
$5.48M
36.3%
ALNY ALNYLAM PHARMACEUTICALS, INC.
2 Oct 2025
CSO & EVP, Head of Research
Sold at will
2,441
$1.10M
8.8%
ALNY ALNYLAM PHARMACEUTICALS, INC.
18 Aug 2025
CSO & EVP, Head of Research
Sold at will
1,396
$632.76K
5.8%
ALNY ALNYLAM PHARMACEUTICALS, INC.
4 Mar 2025
CSO & EVP, Head of Research
Sold on a plan
844
$203.53K
5.9%
ALNY ALNYLAM PHARMACEUTICALS, INC.
3 Mar 2025
CSO & EVP, Head of Research
Sold on a plan
1,911
$465.77K
11.8%
ALNY ALNYLAM PHARMACEUTICALS, INC.
28 Feb 2025
CSO & EVP, Head of Research
Sold at will
496
$119.88K
3.9%
ALNY ALNYLAM PHARMACEUTICALS, INC.
18 Feb 2025
CSO & EVP, Head of Research
Sold on a plan
1,440
$362.24K
10.1%
ALNY ALNYLAM PHARMACEUTICALS, INC.
14 Feb 2025
CSO & EVP, Head of Research
Sold on a plan
663
$169.20K
4.4%
ALNY ALNYLAM PHARMACEUTICALS, INC.
27 Nov 2024
CSO & EVP, Head of Research
Sold on a plan
1,531
$386.26K
10.6%
ALNY ALNYLAM PHARMACEUTICALS, INC.
26 Nov 2024
CSO & EVP, Head of Research
Sold on a plan
1,469
$368.69K
9.3%
ALNY ALNYLAM PHARMACEUTICALS, INC.
12 Aug 2024
CSO & EVP, Head of Research
Sold on a plan
22,025
$5.97M
63.1%
ALNY ALNYLAM PHARMACEUTICALS, INC.
25 Jun 2024
CSO & EVP, Head of Research
Sold at will
1,198
$276.73K
7.8%
20 decisions on file.